Human vaccine development against Rift Valley fever and Chikungunya diseases

Request For Proposals

General Information

   Jan 6, 2019
   National procurement

Original Text

CEPI is pleased to announce its third call for proposals (CfP3i) for the development of human vaccines against Rift Valley Fever (RVF) and Chikungunya (CHIK) disease, with anticipated support from the European Commission. This document describes the scope, requirements, and processes for proposal submission, review, and selection for funding. Further details can be found at
Membership Plans






Price on request

Buy Buy Contact us
Please note that this notice is for your information only.
We try our best to have the most accurate and up-to-date information available on our web site, but we cannot guarantee that all of the information provided is error-free.
If you have any updates, corrections, or complaints related to this notice, please contact the responsible purchaser directly.